SpringWorks Therapeutics, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$5.3M
Doctors Paid
2,426
Transactions
5,727
2024 Total
$5.3M
Payment Breakdown by Category
Research$3.9M (74.1%)
Consulting$310,945 (5.9%)
Food & Beverage$118,638 (2.3%)
Travel$61,901 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.9M | 1,310 | 74.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $797,466 | 152 | 15.2% |
| Consulting Fee | $310,945 | 101 | 5.9% |
| Food and Beverage | $118,638 | 3,835 | 2.3% |
| Grant | $75,500 | 14 | 1.4% |
| Travel and Lodging | $61,901 | 315 | 1.2% |
Payments by Type
Research
$3.9M
1,310 transactions
General
$1.4M
4,417 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| MEK-NF-201 | $1.3M | 0 | 209 |
| NIR-DT-301 | $640,824 | 0 | 107 |
| NIR-OGT-201 | $578,667 | 0 | 607 |
| MEKRAF-AST-101 | $520,520 | 0 | 300 |
| TEAD-AST-101 | $313,065 | 0 | 75 |
| A PHASE II STUDY OF CRYOABLATION PLUS NIROGACESTAT FOR DESMOID TUMOR | $214,983 | 0 | 5 |
| PHASE 1B/2A, OPEN -LABEL PLATFORM STUDY TO EVALUATE MIRDAMETINIB AS MONOTHERAPY OR IN COMBINATION WITH OTHER ANTICANCER AGENTS IN PATIENTS WITH ADVANCED SOLID CANCERS HAROBIRING MAPK-ACTIVATING TUMORS | $49,602 | 0 | 1 |
| A SAFETY,PHARMACOKINETIC AND EFFICACY STUDY OF A ?-SECRETASE INHIBITOR, NIROGACESTAT IN CHILDREN AND ADOLESCENTS WITH PROGRESSIVE, SURGICALLY UNRESECTABLE DESMOID TUMORS | $11,740 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Audrey Green-Murphy, D.o, D.O | Pediatric Hematology-Oncology | Madera, CA | $7,955 | $0 |
| Carlos Romo | Neurology | Baltimore, MD | $7,877 | $0 |
| Raffi Avedian, Md, MD | Orthopaedic Surgery | Stanford, CA | $7,844 | $0 |
| Dr. Anna Chalmers, Md, MD | Internal Medicine | Salt Lake City, UT | $7,573 | $0 |
| Atif Hussein, Md, MD | Hematology & Oncology | Hollywood, FL | $7,528 | $0 |
| Ravin Ratan | Student in an Organized Health Care Education/Training Program | Houston, TX | $7,380 | $0 |
| Elizabeth Davis, Md, MD | Medical Oncology | Nashville, TN | $7,360 | $0 |
| Dr. Steven Rhodes, M.d., Ph.d, M.D., PH.D | Pediatric Hematology-Oncology | Indianapolis, IN | $7,150 | $0 |
| Maya Hrachova | Neurology | Minneapolis, MN | $7,005 | $0 |
| Dr. Tobias Walbert, M.d., Ph.d, M.D., PH.D | Neurology | Detroit, MI | $6,900 | $0 |
| Dr. Lionel Chow, Md, Phd, MD, PHD | Pediatric Hematology-Oncology | Dayton, OH | $6,370 | $0 |
| Dr. Yoon Jae Choi, Md, MD | Neurology | Orange, CA | $5,914 | $0 |
| Dr. Brian Na, M.d, M.D | Pediatric Hematology-Oncology | Los Angeles, CA | $5,851 | $0 |
| Dr. Dale Shepard, M.d., Ph.d, M.D., PH.D | Hematology & Oncology | Cleveland, OH | $5,740 | $0 |
| Laith Abushahin, Mbbs, MBBS | Internal Medicine | Dallas, TX | $5,372 | $0 |
| Erika Santos Horta, M.d, M.D | Neurology | Oklahoma City, OK | $5,349 | $0 |
| Kevin Bielamowicz | Pediatric Hematology-Oncology | Little Rock, AR | $5,254 | $0 |
| Dr. Alipi Bonm, Md Phd, MD PHD | Neurology | Seattle, WA | $5,071 | $0 |
| Tena Rosser, M.d, M.D | Neurology with Special Qualifications in Child Neurology | Los Angeles, CA | $5,000 | $0 |
| Laurie Mckenzie, M.d, M.D | Obstetrics & Gynecology | Houston, TX | $4,900 | $0 |
| Emily Jonczak, M.d, M.D | Hematology & Oncology | Miami, FL | $4,705 | $0 |
| Dr. Daniel Lefler, Md, MD | Internal Medicine | Philadelphia, PA | $4,628 | $0 |
| Mina Lobbous | Neurology | Birmingham, AL | $4,443 | $0 |
| Dr. Victoria Rizk, M.d, M.D | Hematology & Oncology | Basking Ridge, NJ | $4,257 | $0 |
| Dr. Seema Nagpal, M.d, M.D | Neurology | Stanford, CA | $3,908 | $0 |
About SpringWorks Therapeutics, Inc.
SpringWorks Therapeutics, Inc. has made $5.3M in payments to 2,426 healthcare providers, recorded across 5,727 transactions in the CMS Open Payments database. In 2024, the company paid $5.3M. The top product by payment volume is OGSIVEO ($493,656).
Payments were distributed across 79 medical specialties. The top specialty by payment amount is Hematology & Oncology ($199,702 to 763 doctors).
Payment categories include: Food & Beverage ($118,638), Consulting ($310,945), Research ($3.9M), Travel & Lodging ($61,901).
SpringWorks Therapeutics, Inc. is associated with 1 products in the CMS Open Payments database.